Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance

Antioxidants and Redox Signaling

Volumn 8, Issue 7-8, 2006, Pages 1131-1140

  Busija, David W ^a   Miller, Allison W ^a   Katakam, Prasad ^a   Erdos, Benedek ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; BORON DERIVATIVE; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN SENSITIZING AGENT; METFORMIN; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; VASOCONSTRICTOR AGENT;

ANTIOXIDANT ACTIVITY; ARTERIOLE; ARTERY; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY WALL; BEHAVIOR MODIFICATION; BIOAVAILABILITY; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; DIET; EXERCISE; HUMAN; HYPOTENSION; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WEIGHT REDUCTION;

ACETYLCHOLINE; ANIMALS; BASILAR ARTERY; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; FORECASTING; FREE RADICAL SCAVENGERS; HYPERTENSION; INSULIN RESISTANCE; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS; RATS; RATS, ZUCKER; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

ANIMALIA;

EID: 33746835714     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1131     Document Type: Review

References (119)

1. Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafe M, Barbieri Corsi AM, Lauretani F, Franceschi C, and Paolisso G. Diverse effect of inflammatory markers on insulin resistance and insulin resistant syndrome in the elderly. J Am Geriatr Soc 52: 399-404, 2004.
2. Armstead WM. Vasopressin-induced protein kinase C-dependent superoxide generation contributes to ATP-sensitive potassium channel but not calcium-sensitive potassium channel function impairment after brain injury. Stroke 32: 1408-1414, 2001.
3. Balletshofer BM, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K, and Haring HU. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 171: 303-309, 2003.
4. Bari F, Louis TM, Meng W, and Busija DW. Global ischemia impairs ATP-sensitive K+ channel function in cerebral arterioles in piglets. Stroke 27: 1874-1881, 1996.
5. Bloomgarden ZT. Mediators, pediatrie insulin resistance, the polycystic ovary syndrome, and malignancy. Diabetes Care 28: 1821-1830, 2005.
6. Brook RD, Bard RL, Glazewski L, Kehrer C, Bodary PF, Eitzman DL, Rajagopalan S. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 93: 1012-1016, 2004.
7. Busija DW Prostaglandins and other eicosanoids. In: Cerebral Blood Flow and Metabolism, Edvinnson L and Krause D, eds. Philadelphia: Lippincott Williams & Wilkins, 2002; 325-338.
8. Ceriello A and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816-823, 2004.
9. Campia U, Sullivan G, Bryant MB, Waclawiw MA, Quon MJ, and Panza JA. Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile. Am J Physiol Heart Circ Physiol 286: H76-H82, 2004.
10. Carlson GL. Hunterian Lecture: Insulin resistance in human sepsis: Implications for the nutritional and metabolic care of the critically ill surgical patient. Ann R Coll Surg Engl 86: 75-81, 2004.
11. Carmassi F, De Negri F, Fioriti R, DeGiorgi A, Giannarelli C, Fruzzetti F, Pedrinelli R, Dell'omo G, and Bersi C. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome. Thromb Res 116: 207-214, 2005.
12. Conti M, Renaud IM, Poirier B, Michel O, Belair MF, Mandet C, Brune P, Myara I, and Chevalier J. High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. Am J Physiol Regul Integr Comp Physiol 286: R793-R800, 2004.
13. Dagres N, Sailer B, Haude M, Husing J, von Birgelen C, Schmermund A, Sack S, Baumgart D, Mann K, and Erbel R. Insulin sensitivity and coronary vasoreactivity: Insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol 61: 724-731, 2004.
14. de la Torre JC. Impaired cerebromicrovascular perfusion: summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci 924: 136-152, 2000.
15. Diamanti-Kandarakis E, Alexandraki K, Protogerou A, Piperi C, Papamichael C, Aessopos A, Lekakis J, and Mavrikakis M. Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol 152: 749-756, 2005.
16. Didion SP, Lynch CM, Baumbach GL, and Faraci FM. Impaired endothelium-dependent responses and enhanced influences of Rho-kinase in cerebral arterioles in type II diabetes. Stroke 36: 342-347, 2005.
17. Dimitropoulou C, Han G, Miller AW, Molero M, Fuchs LC, White RE, and Carrier GO. Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282: H908-H917, 2002.
18. Di Napoli M. Benefits of statins in cerebrovascular disease. Invest Drugs 5: 295-305, 2004.
19. Dogra GK, Hermann S, Irish AB, Thomas MA, and Watts GF. Insulin resistance, dylipidaemia, inflammation and endothelial function in nephritic syndrome. Nephrol Dial Transplant 17: 2220-2225, 2002.
20. Domoki F, Velkamp R, Thrikawala N, Robins G, Bari F, Louis TM, and Busija DW. Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteries. Am J Physiol Heart Circ Physiol 277: H1207-H1214, 1999.
21. Donnelly R and Qu X. Mechanisms of insulin resistance and new pharmacologic approaches to metabolism and diabetic complications. Clin Exp Pharmacol Physiol 25: 79-87, 1998.
22. Dumont AS, Hyndman ME, Dumont RJ, Fedak PM, Kassell NF, Sutherland GR, and Verma S. Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. J Neurosurg 95: 466-471, 2001.
23. Durbin RJ. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes Obesity Metab 6: 280-285, 2004.
24. Erdös B, Miller AW, and Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282: H2060-H2065, 2002.
25. ATP and KCa channel function in cerebral arteries of insulin resistant rats. Am J Physiol Heart Circ Physiol 283: H2472-H2477, 2002.
26. Erdös B, Simandle SA, Snipes JA, Miller AW, and Busija DW. Potassium channel dysfunction in cerebral arteries of insulin-resistant rats is mediated by reactive oxygen species. Stroke 35: 964-969, 2004.
27. Erdös B, Snipes JA, Miller AW, and Busija DW Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53: 1352-1359, 2004.
28. Erdös B, Snipes JA, Kis B, Miller AW, and Busija DW. Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance. Am J Physiol Regul Integr Comp Physiol 287: R1456-R1461, 2004.
29. Erdös B, Snipes JA, Tulbert CD, Katakam P, Miller AW, and Busija DW. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H-oxidase-dependent Superoxide production. Am J Physiol Heart Circ Physiol 290(3): H1264-1270, 2006.
30. Eschwege E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: Aetiological factors in the development of CV complications. Diabetes Metab 29: 6819-6827, 2003.
31. Faraci FM. Oxidative stress: The curse that underlies cerebral vascular dysfunction? Stroke 36: 186-188, 2005.
32. Faraci FM and Heistad DD. Regulation of potassium channels in regulation of cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 78: 53-97, 1998.
33. Ford ES, Giles WH, and Dietz WH. Prevalence of the metabolic syndrome among U.S. adults: Findings from the third National Health and Nutrition Examination Survey. J Clin Invest 287: 356-359, 2002.
34. Frisbee JC. Enhanced arteriolar a-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97: 764-772, 2004.
35. Frisbee JC and Stepp DW. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281: H1304-1311, 2001.
36. Garlid KD and Paucek P. Mitochondrial potassium transport: the K (+) cycle. Biochim Biophys Acta 1606: 23-41, 2003.
37. Grant RW and Meigs JB. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging 21: 141-151, 2004.
38. Grundy SM, Hansen B, Smith SC, Cleeman JI, and Kahn RA, for Conference Participants. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109: 551-556, 2004.
39. Gustafson D, Rothenberg E, Blennow K, Steen B, and Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163: 1524-1528, 2003.
40. Gutterman DD, Miura H, and Liu Y. Redox modulation of vascular tone: Focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 25: 671-678, 2005.
41. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, and Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
42. Hidvegi T, Szatmari F, Hetyesi K, Biro L, and Jermendy G. Intima-media thickness of the carotid arteries in subjects with hyperinsulinaemia (insulin resistance). Diabetes Nutr Metab 16: 139-144, 2003.
43. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, Kugiyama K, Ogawa H, and Yasue H. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol 35: 1860-1866, 2000.
44. Holness MJ, Smith ND, Greenwood GK, and Sugden MC. Acute omega-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance. Diabetes 53(suppl 1): S166-S171, 2004.
45. Hotamisligil GS. The role of TNFα and TNF receptors in obesity and insulin resistance. J Intern Med 245: 621-625, 1999.
46. Jorgensen H, Nakayama H, Raaschou HO, and Olsen TS. Stroke in patients with diabetes: The Copenhagen Stroke Study. Stroke 25: 1977-1984, 1994.
47. Karagiannis J, Reid JJ, Darby I, Roche P, Rand MJ, and Li CG. Impaired nitric oxide function in the basilar artery of the obese Zucker rat. J Cardiovasc Pharmacol 42: 497-505, 2003.
48. Kashiwagi A, Shinozaki K, Nishio Y, Okamura T, Toda N, and Kikkawa R. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state. Diabetes Res Clin Pract 45: 199-203, 1999.
49. Katakam PV, Hoenig M, Ujhelyi MR, and Miller AW. Cytochrome P450 activity and endothelial dysfunction in insulin resistance. J Vasc Res 37: 426-434, 2000.
50. Katakam PV, Pollock JS, Pollock DM, Ujhelyi MR, and Miller AW. Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats. Am J Physiol Heart Circ Physiol 280: H522-H527, 2001.
51. Katakam PVG, Tulbert CD, Snipes JA, Erdos B, Miller AW, and Busija DW Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species. Am J Physiol Heart Circ Physiol 288: H854-H860, 2005.
52. Katakam PV, Ujhelyi MR, and Miller AW. EDHF-mediated relaxation is impaired in fructose-fed rats. J Cardiovasc Pharmacol 34: 461-467, 1999.
53. Katakam PV, Ujhelyi MR, Hoenig ME, and Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 275: R788-R792, 1998.
54. Katakam PV, Unjelyi MR, Hoenig M, and Miller A.W. Metformin improves vascular function in insulin-resistant rats. Hypertension 35: 108-112, 2000.
55. Kawaguchi M, Koshimura K, Sohmiya M, Murakami Y, Gonda T, and Kato Y. Effect of insulin on nitric oxide synthase-like immunostaining of arteries in various organs in Zucker diabetic fatty rats. Eur J Endocrinol 145: 343-349, 2001.
56. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, and Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87: 742-746, 2002.
57. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, and King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin. Circulation 101: 676-681, 2000.
58. Kudo T, Imaizumi K, Tanimukai H, Katayama T, Sato N, Nakamura Y, Tanaka T, Kashiwagi Y, Jinno Y, Tohyama M, and Takeda M. Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging 11: 215-224, 2000.
59. Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, and Busija DW Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol 281: H406-H411, 2002.
60. Lamonte MJ, Blair SN, and Church TS. Physical activity and diabetes prevention. J Appl Physiol 99: 1205-1213, 2005.
61. Lee HB, Yu MR, Song JS, and Ha H. Reactive oxygen species amplify protein kinase G signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65: 1170-1179, 2004.
62. Liu Y and Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol 29: 305-311, 2002.
63. Liu Y, Terata K, Rusch NJ, and Gutterman DD. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 89: 146-152, 2001.
64. Ma Y, Toth B, Keeton AB, Holland LT, Chaudry IH, and Messina JL. Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 145: 5168-5176, 2004.
65. Ma Y, Wang P, Kuebler JF, Chaudry IH, and Messina JL. Hemorrhage induces the rapid development of hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 284: G107-G115, 2003.
66. Maki KC. Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am J Cardiol 93(suppl): 12C-17C, 2004.
67. Matsumoto K, Miyake S, Yano M, Ueki Y, Miyazaki A, Hirao K, and Tominaga Y. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care 22: 1191-1195, 1999.
68. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892: 146-154, 1999.
69. Mayhan WG. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res 760: 204-209, 1997.
70. Mayhan WG, Mayhan JF, Sun H, and Patel KP. In vivo properties of potassium channels in cerebral blood vessels during diabetes mellitus. Microcirculation 11: 605-613, 2004.
71. Meriden T. Progress with thiazolidinediones in the management of type 2 diabetes mellitus. Clin Ther 26: 177-190, 2004.
72. Metzger BL. The effect of a genetic variant for obesity and type 2 diabetes on the therapeutic potential of exercise and caloric restrictive diets in Zucker rats. Res Theory Nurs Pract 17: 321-333, 2003.
73. Miatello R, Cruzado M, and RislerN. Mechanisms of cardiovascular changes in an experimental model of syndrome X and pharmacological intervention on the reninangiotensin system. Curr Vasc Pharmacol 2: 371-377, 2004.
74. Miller AW, Dimitropoulou C, Han G, White RE, Busija DW, and Carrier GO. Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance. Am J Physiol Heart Circ Physiol 281: H1524-H1531, 2001.
75. Miller AW, Hoenig ME, and Ujhelyi MR. Mechanisms of impaired endothelial function associated with insulin resistance. J Cardiovasc Pharmacol Ther 3: 125-134, 1998.
76. Miller AW, Katakam PV, and Ujhelyi MR. Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats. J Vasc Res 36: 385-392, 1999.
77. Miller AW, Tulbert CD, Puskar M, and Busija DW. Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance. Hypertension 40: 78-82, 2002.
78. Miller AW, Tulbert CD, and Busija DW Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin resistant rats. Am J Physiol Regul Integr Comp Physiol 287: R157-R160, 2004.
79. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, Magny JF, Roger M, and Voyer M. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely pre-term infants. Pediatrics 113: 537-541, 2004.
80. Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, and Gutterman DD. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: Reduced activity of ATP-sensitive potassium channels. Circ Res 92: 151-158, 2003.
81. Mohazzab KM, Kaminski PM, and Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol Heart Circ Physiol 266: H2586-H2572, 1994.
82. Natali A, Baldeweg S, Toschi E, Capaldo B, Barbara D, Gastaldelli A, Yudkin JS, and Ferrannini E. Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care 27: 1349-1357, 2004.
83. Okon EB, Chug AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, Luo H, and van Breemen C. Compromised arterial function in human type 2 diabetic patients. Diabetes 54: 2415-2423, 2005.
84. Otani H. Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. Antioxid Redox Signal 6: 449-469, 2004.
85. Pamies-Andreu E, Fiksen-Olsen M, Rizza RA, Romero JC. High-fructose feeding elicits insulin resistance without hypertension in normal mongrel dogs. Am J Hypertens 8: 732-738, 1995.
86. Phillips SA, Sylvester FA, and Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R522-R530, 2005.
87. Pleiner J, Schaller G, mittermayer F, Bayerle-Eder M, Roden M, and Wolzt M, FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab 87: 2913-2917, 2002.
88. Pricci F, Leto G, Amadio L, Iacobini C, Cordone S, Catalano S, Zicari A, Sorcini M, Di Mario U, and Pugliese G. Oxidative stress in diabetes-induced endothelial dysfunction: involvement of nitric oxide and protein kinase C. Free Radic Biol Med35: 683-694, 2003.
89. Quinones MJ, Hernandez-Pamploni M, Schelbert H, Bulnes-Enriquez, Jimenez X, Hernandez G, De La Rosa R, Chon Y, Yang H, Nicholas SB, Modilevsky T, Yu K, Van Herle K, Castellani LW, Elashoff R, and Hsueh WA. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med 140: 700-708, 2004.
90. Razay G and Wilcock GK. Hyperinsulinaemia and Alzheimer's disease. Age Ageing 23: 396-399, 1994.
91. Sakkinen PA, Whal P, Cushman M, Lewis MR, and Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152: 897-907, 2000.
92. Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, and Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 47: 270-275, 1998.
93. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: Part 2: Overview of physiological and biochemical mechanism. Diabetes Metab 30: 498-505, 2004.
94. Schunkert H. Obesity and target organ damage: The heart. Int J Obes Relat Metab Disord 4: S15-S20, 2002.
95. Schwaninger RM, Sun H, and Mayhan WG. Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci 73: 3415-3425, 2003.
96. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, and Harano Y. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 27: 37-43, 1996.
97. Sjoholm A and Nystrom T. Endothelial inflammation in insulin resistance. Lancet 365: 610-612, 2005.
98. Sharma AM. Is there a rationale for angiotensin blockade in the management of obesity hypertension? Hypertension 44: 12-19, 2004.
99. Shinozaki K, Hirayama A, Nishio Y, Yoshida Y, Ohtani T, Okamura T, Masada M, Kikkawa R, Kodama K, and Kashiwagi A. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 38: 1821-1828, 2001.
100. Shinozaki K, Kashiwagi A, Masada M, and Okamura T. Molecular mechanisms of impaired endothelial function associated with insulin resistance. Curr Drug Targets Cardiovasc Haematol Disord 4: 1-11, 2004.
101. 2 imbalance in insulin- resistant rat aorta. Diabetes 48: 2437-2445, 1999.
102. Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 20: 295-304, 2004.
103. Simandle SA, Erdös B, Snipes JA, Miller AW, and Busija DW. Insulin resistance does not impair contractile responses of cerebral arteries. Life Sci 77: 2262-2272, 2005.
104. Steinberg HO and Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 45: 623-634, 2002.
105. Steppan CM and Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13: 18-23, 2002.
106. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286: H1597-H1602, 2004.
107. Sun CK, Zhang XY, and Wheatley AM. Increased NAD(P)H fluorescence with decreased blood flow in the steatotic liver of the obese Zucker rat. Microvasc Res 66: 15-21, 2003.
108. Tang XD, Garcia ML, Heinemann SH, and Hoshi T. Reactive oxygen species impairs S1o1 BK channel function by altering cysteine-mediated calcium sensing. Nat Struct Mol Biol 11: 171-178, 2004.
109. Turner R (UK Prospective Diabetes Study UKPDS Group). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes IUKPDS 34). Lancet 352: 854-865, 1998.
110. Turtle JR. The economic burden of insulin resistance. Int J Clin Pract Suppl 113: 23-28, 2000.
111. Voko Z, Hollander M, Hofman A, Koudstaal PJ, and Breteler MM. Dietary antioxidants and the risk of ischemic stroke: The Rotterdam study. Neurology 61: 1273-1275, 2003.
112. Wagh A and Stone NJ. Expert review of cardiovascular therapy. Exp Rev Cardiovasc Ther 2: 213-228, 2004.
113. Watson GS and Craft S. The role of insulin resistance in the pathogenesis of Alzheimer's disease: Implications for treatment. CNS Drugs 17: 27-45, 2003.
114. Wiernsperger NF and Bouskela E. Microcirculation in insulin resistance and diabetes: more than just a complication. Diabetes Metab 29: 6S77-6S87, 2003.
115. Wisse BE. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. JAm Soc Nephrol 15: 2792-2800, 2004.
116. Yamashita T, Murakami T, Iida M, Kuwajima M, and Shima K. Leptin receptor of Zucker fatty rat performs reduced signal transduction. Diabetes 46: 1077-1080, 1997.
117. Vollenwieder P. Insulin resistant states and insulin signaling. Clin Chem Lab Med 41: 1107-1119, 2003.
118. Xiang AH, Peters RK, Kjos SL, Goico J, Ochoa C, Marroquin A, Tan S, Hodis HN, Azen SP, and Buchanan TA. Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: Impact on glucose tolerance and β-cell function. J Clin Endocrinol Metab 89: 2846-2851, 2004.
119. Zhou W, Wang ZL, Kaduce TL, Spector AA, and Lee HC. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288: H2210-2218, 2005.